Consistent with these data, the abundance of phosphor-IWS1 and the U2AF2 E2/E3 ratio, correlates positively with tumor stage (Fig. 8c) and negatively with survival in patients with EGFR mutant, but not KRAS mutant tumors (Fig. 8d). This evidence concerns the gene U2AF2 and neoplasm.